Johns Hopkins HIV Guide
Pyrazinamide
INDICATIONS
FDA
FDA
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: September 28, 2018
Citation
Avdic, Edina, and Paul A Pham. "Pyrazinamide." Johns Hopkins HIV Guide, 2018. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545174/all/Pyrazinamide.
Avdic E, Pham PA. Pyrazinamide. Johns Hopkins HIV Guide. 2018. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545174/all/Pyrazinamide. Accessed December 5, 2023.
Avdic, E., & Pham, P. A. (2018). Pyrazinamide. In Johns Hopkins HIV Guide https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545174/all/Pyrazinamide
Avdic E, Pham PA. Pyrazinamide [Internet]. In: Johns Hopkins HIV Guide. ; 2018. [cited 2023 December 05]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545174/all/Pyrazinamide.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Pyrazinamide
ID - 545174
A1 - Avdic,Edina,Pharm.D.
AU - Pham,Paul,Pharm.D.
Y1 - 2018/09/28/
BT - Johns Hopkins HIV Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545174/all/Pyrazinamide
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
